Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis

Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients...

Full description

Bibliographic Details
Published in:ERJ Open Research
Main Author: George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
Format: Article
Language:English
Published: European Respiratory Society 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c
id 2-s2.0-85211349800
spelling 2-s2.0-85211349800
George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
2024
ERJ Open Research
10
6
10.1183/23120541.00570-2024
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c
Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients with IPF were accessed from the Open Source Imaging Consortium database. Automated computed tomography (CT) biomarkers of disease severity incorporating fibrotic and pulmonary vascular features (the reticulovascular score and weighted reticulovascular score (WRVS)) were studied. Relationships between imaging biomarkers, lung function and survival were analysed. Results In separate test and validation cohorts, 168 and 176 patients with IPF respectively (median survival 2.6 years) were studied. A threshold of WRVS ⩾15% at baseline CT was most strongly associated with transplant-free survival (HR 3.00, 95% CI 1.47–6.10, p=0.002) when adjusted for baseline forced vital capacity (FVC) and age. In patients with 12-month follow-up CT and lung function tests (n=89) an increase in 3% of WRVS (the minimal clinically important difference) was also significantly associated with reduced survival independent of FVC, and outperformed visual evaluation of progressive fibrosis. Conclusions WRVS is an automated CT biomarker which can identify patients with IPF at increased risk of progression and is able to reliably capture disease progression over time. © The authors 2024.
European Respiratory Society
23120541
English
Article
All Open Access; Gold Open Access; Green Open Access
author George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
spellingShingle George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
author_facet George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
author_sort George P.M.; Rennison-Jones C.; Benvenuti G.; Sifostratoudaki A.; Ottink F.A.; Bou-Zeid W.; Ledda R.E.; Abul Kadir R.F.; Johari B.; Fernandez C.; Harston G.W.J.; Joly O.; Gerry S.; Devaraj A.
title Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
title_short Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
title_full Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
title_fullStr Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
title_full_unstemmed Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
title_sort Evaluation of e-Lung automated quantitative computed tomography biomarkers in idiopathic pulmonary fibrosis
publishDate 2024
container_title ERJ Open Research
container_volume 10
container_issue 6
doi_str_mv 10.1183/23120541.00570-2024
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-85211349800&doi=10.1183%2f23120541.00570-2024&partnerID=40&md5=5288db6846ea8f9b950fb88d047d289c
description Background In patients with idiopathic pulmonary fibrosis (IPF) there is a need to identify biomarkers that 1) are associated with increased risk of adverse outcome and 2) can be used to monitor treatment response or identify disease progression over time. Methods Two consecutive cohorts of patients with IPF were accessed from the Open Source Imaging Consortium database. Automated computed tomography (CT) biomarkers of disease severity incorporating fibrotic and pulmonary vascular features (the reticulovascular score and weighted reticulovascular score (WRVS)) were studied. Relationships between imaging biomarkers, lung function and survival were analysed. Results In separate test and validation cohorts, 168 and 176 patients with IPF respectively (median survival 2.6 years) were studied. A threshold of WRVS ⩾15% at baseline CT was most strongly associated with transplant-free survival (HR 3.00, 95% CI 1.47–6.10, p=0.002) when adjusted for baseline forced vital capacity (FVC) and age. In patients with 12-month follow-up CT and lung function tests (n=89) an increase in 3% of WRVS (the minimal clinically important difference) was also significantly associated with reduced survival independent of FVC, and outperformed visual evaluation of progressive fibrosis. Conclusions WRVS is an automated CT biomarker which can identify patients with IPF at increased risk of progression and is able to reliably capture disease progression over time. © The authors 2024.
publisher European Respiratory Society
issn 23120541
language English
format Article
accesstype All Open Access; Gold Open Access; Green Open Access
record_format scopus
collection Scopus
_version_ 1820775431554465792